Status:
COMPLETED
Elemental Formula in Neonates Post Small Bowel Resection: Improved Weaning From Total Parenteral Nutrition?
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Short Bowel Syndrome
Eligibility:
All Genders
Up to 1 years
Phase:
NA
Brief Summary
In neonates with recent small bowel resection or congenital bowel anomalies (gastroschisis or omphalocele), does an elemental formula as compared to a partially hydrolyzed formula allowed the infant t...
Detailed Description
Neonates with short bowel syndrome (SBS) due to recent small bowel resection or congenital bowel anomalies (gastroschisis or omphalocele) can have inability to adequately digest and absorb enteral fee...
Eligibility Criteria
Inclusion
- Term or pre-term neonates with either surgical resection of the small bowel or congenital bowel anomalies (gastroschisis, omphalocele) unable to tolerate 90kcal/kg/day of enteral feedings by 1 month of age
Exclusion
- Term or preterm neonates with NEC totalis,
- Inborn Errors of Metabolism, or
- Known or suspected congenital syndromes
Key Trial Info
Start Date :
September 26 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 17 2013
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT01891279
Start Date
September 26 2011
End Date
September 17 2013
Last Update
May 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030